PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE:

# Drug Count
0 AZATHIOPRINE 2
1 INFLIXIMAB 2
2 CYTARABINE 1
3 DOXORUBICIN 1
4 ETOPOSIDE 1
5 NELARABINE 1
6 VENETOCLAX 1
See all common drugs associated with PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE

PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NELARABINE 1 0.0010
1 AZATHIOPRINE 2 0.0000
2 CYTARABINE 1 0.0000
3 VENETOCLAX 1 0.0000
4 ETOPOSIDE 1 0.0000
5 DOXORUBICIN 1 0.0000
6 INFLIXIMAB 2 0.0000
See all drugs enriched for association with PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE

PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Purine Antimetabolite [EPC] 2 0.0000
1 BCL-2 Inhibitor [EPC] 1 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
4 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
See all drug classes enriched for association with PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE